AU623463B2 - Swelling-controlled oral delivery system for drugs - Google Patents

Swelling-controlled oral delivery system for drugs Download PDF

Info

Publication number
AU623463B2
AU623463B2 AU47123/89A AU4712389A AU623463B2 AU 623463 B2 AU623463 B2 AU 623463B2 AU 47123/89 A AU47123/89 A AU 47123/89A AU 4712389 A AU4712389 A AU 4712389A AU 623463 B2 AU623463 B2 AU 623463B2
Authority
AU
Australia
Prior art keywords
poly
acid
delivery system
drug
resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47123/89A
Other languages
English (en)
Other versions
AU4712389A (en
Inventor
Robert Ziolkowski Greenley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of AU4712389A publication Critical patent/AU4712389A/en
Application granted granted Critical
Publication of AU623463B2 publication Critical patent/AU623463B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU47123/89A 1988-12-22 1989-12-21 Swelling-controlled oral delivery system for drugs Ceased AU623463B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28806588A 1988-12-22 1988-12-22
US288065 1988-12-22

Publications (2)

Publication Number Publication Date
AU4712389A AU4712389A (en) 1990-06-28
AU623463B2 true AU623463B2 (en) 1992-05-14

Family

ID=23105595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47123/89A Ceased AU623463B2 (en) 1988-12-22 1989-12-21 Swelling-controlled oral delivery system for drugs

Country Status (5)

Country Link
EP (1) EP0375649A3 (fr)
JP (1) JPH02212416A (fr)
AU (1) AU623463B2 (fr)
CA (1) CA2006268A1 (fr)
ES (1) ES2017454A4 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR062846A1 (es) 2007-09-13 2008-12-10 Lombardo Fabio Martin Metodo para la incorporacion de moleculas bioactivas en un sustrato polimerico resistente a los acidos estomacales, para su utilizacion como medicamento oral de liberacion retardada, particularmente moleculas de insulina, y el medicamento asi obtenido

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6820687A (en) * 1986-02-03 1987-08-06 Elan Corporation, Plc Drug delivery system
AU4022689A (en) * 1988-08-24 1990-03-01 Ciba Specialty Chemicals Water Treatments Limited Polymeric particulate compositions and methods of producing them
AU4557889A (en) * 1988-11-28 1990-05-31 Noveon Ip Holdings Corp. Crosslinked polyacrylic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (fr) * 1960-06-06
GB1124115A (en) * 1965-07-20 1968-08-21 Fisons Pharmaceuticals Ltd Tablet formulation
USRE28316E (en) * 1968-09-03 1975-01-21 Entrapment compositions and processes
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
EP0205336B1 (fr) * 1985-06-11 1991-09-11 Teijin Limited Préparation pharmaceutique orale à effet entretenn

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6820687A (en) * 1986-02-03 1987-08-06 Elan Corporation, Plc Drug delivery system
AU4022689A (en) * 1988-08-24 1990-03-01 Ciba Specialty Chemicals Water Treatments Limited Polymeric particulate compositions and methods of producing them
AU4557889A (en) * 1988-11-28 1990-05-31 Noveon Ip Holdings Corp. Crosslinked polyacrylic acid

Also Published As

Publication number Publication date
EP0375649A2 (fr) 1990-06-27
AU4712389A (en) 1990-06-28
ES2017454A4 (es) 1991-02-16
EP0375649A3 (fr) 1992-05-27
CA2006268A1 (fr) 1990-06-22
JPH02212416A (ja) 1990-08-23

Similar Documents

Publication Publication Date Title
AU727053B2 (en) Method for oral delivery of proteins
Foss et al. Development of acrylic-based copolymers for oral insulin delivery
Chen et al. Gastric retention properties of superporous hydrogel composites
AU713722B2 (en) Gastrointestinal drug delivery system
Hussain et al. Water uptake and drug release behaviour of methyl methacrylate-co-itaconic acid [P (MMA/IA)] hydrogels cross-linked with methylene bis-acrylamide
Ramkissoon-Ganorkar et al. Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight
Omidian et al. Recent developments in superporous hydrogels
Jiménez-castellanos et al. Mucoadhesive drug delivery systems
Morishita et al. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption
CA2305762C (fr) Systeme d'administration de medicaments a liberation totale prolongee destines au tractus gastro-intestinal
US5840329A (en) Pulsatile drug delivery system
Kumar et al. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery
EP0274734A1 (fr) Comprimé à usage pharmaceutique à libération à temps successifs
JPH0830004B2 (ja) 生物接着性組成物およびそれにより治療する方法
WO1990004386A1 (fr) Preparations pharmaceutiques orales a acheminement selectif au colon
CN108653234B (zh) 载有多肽蛋白类药物的固体颗粒物及包含该颗粒物的双肠溶固体制剂、其制备方法及用途
JP2002537321A5 (fr)
WO2003007913A2 (fr) Nouveau procede d'administration orale d'un medicament
Narayani et al. Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans
AU623463B2 (en) Swelling-controlled oral delivery system for drugs
US5698515A (en) Insulin-containing polymer composition for oral administration
Ramkissoon-Ganorkar et al. Effect of ionic strength on the loading efficiency of model polypeptide/protein drugs in pH-/temperature-sensitive polymers
EP0993305A2 (fr) Composition en vue d'une meilleure assimilation par les muqueuses de medicaments a molecules polaires
Tirosh et al. The effect of Eudragit RL-100 on the mechanical and mucoadhesion properties of polycarbophil dosage forms
US20130195975A1 (en) In vivo use of water absorbent polymers